Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0032749
Disease: Post-kala-azar dermal leishmaniasis
Post-kala-azar dermal leishmaniasis
0.010 Biomarker disease BEFREE Subclass enzyme-linked immunosorbent assay analysis further revealed enhanced IgG2 and IgG3 anti-gal titers in patients with PKDL compared to control subjects. 31397399 2020
CUI: C0035436
Disease: Rheumatic Fever
Rheumatic Fever
0.010 Biomarker disease BEFREE Humoral immunity in response to M protein, an antigen implicated in ARF pathogenesis, was completely polarized to IgG3 in the patient group. 31742781 2020
CUI: C0040425
Disease: Tonsillitis
Tonsillitis
0.010 GeneticVariation disease BEFREE Patients with recurrent tonsillitis had significantly lower mean of most assessed immunoglobulins: IgA (P = 0.002), IgM (P = 0.003), IgG (P < 0.0001), IgG1 (P < 0.0001) and IgG3 (P < 0.0001) compared to normal subjects; with no significant difference in mean of IgG2 (P = 0.395) and IgG4 (P = 0.105). 31445931 2020
CUI: C0272118
Disease: Warm autoimmune hemolytic anemia
Warm autoimmune hemolytic anemia
0.010 Biomarker disease BEFREE We observed more wAIHA patients with high titer of IgG1 and high prevalence of IgG1+IgG3 and consider that patients without hemolysis having identical results might be interesting to find out how they are protected from damage by RBC autoAbs. 31708346 2020
CUI: C0012546
Disease: Diphtheria
Diphtheria
0.010 Biomarker disease BEFREE IgG1, IgG2b, and IgG3 titers against diphtheria toxoid (DT), pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (Prn) were measured in mice from 28 different inbred and wild-derived strains vaccinated with an aluminum hydroxide-adjuvanted DTaP vaccine. 31547158 2019
CUI: C0017205
Disease: Gaucher Disease
Gaucher Disease
0.010 AlteredExpression disease BEFREE In addition, it is found significantly lower IgG2 levels and significantly higher IgG3 levels in the GD group than in the control group (P<0.001 and <0.006, respectively). 31385859 2019
CUI: C0018794
Disease: Heart Block
Heart Block
0.010 Biomarker disease BEFREE Our data suggest that anti-contactin-1 IgG3 induces an acute conduction block that is most probably mediated by autoantibody binding and subsequent complement deposition and may account for acute onset of disease in these patients. 30953561 2019
CUI: C0019693
Disease: HIV Infections
HIV Infections
0.010 Biomarker group BEFREE HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya. 31470903 2019
CUI: C0023434
Disease: Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
0.010 Biomarker disease BEFREE In this multicenter prospective study, we investigated whether heavy + light chains (HLC: IgGκ, IgGλ, IgAκ, IgAκ, IgMκ, IgMλ) and IgG subclasses (IgG1, IgG2, IgG3, and IgG4) could be used as novel prognostic markers of immunoparesis in 105 treatment-naïve patients with CLL. 31278876 2019
CUI: C0024143
Disease: Lupus Nephritis
Lupus Nephritis
0.010 AlteredExpression disease BEFREE Our results suggest that capillary loop deposition of IgG3 is associated with disease activity in lupus nephritis.. 30431429 2019
CUI: C0025958
Disease: Microcephaly
Microcephaly
0.010 Biomarker disease BEFREE However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. 30856223 2019
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.010 AlteredExpression disease BEFREE Using multiple variable linear regression analyses, we observed higher levels of anti-α-syn IgG1 and IgG3 NAbs in MSA vs. PD, higher levels of anti-α-syn IgG2 NAbs in PD compared to controls, whereas anti-α-syn IgG4 NAbs were reduced in PD compared to MSA and controls. 31616427 2019
CUI: C0030805
Disease: Bullous pemphigoid
Bullous pemphigoid
0.010 Biomarker disease BEFREE The mild clinical phenotype of BP230-type BP may correlate with the weaker deposition of IgG1, IgG3 and complement in the skin lesions. 30394605 2019
CUI: C0034494
Disease: Rabies (disorder)
Rabies (disorder)
0.010 Biomarker disease BEFREE With the goal of identifying a humoral correlate of vaccine-induced protection, pre- and post-vaccination sera from children vaccinated with the AMA1 vaccine and from a control group that received a rabies vaccine were tested for AMA1-specific immunoglobulin G (IgG) subclasses (IgG1, IgG2, IgG3, and IgG4) and for antibody avidity. 30658710 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.010 Biomarker group BEFREE The mild clinical phenotype of BP230-type BP may correlate with the weaker deposition of IgG1, IgG3 and complement in the skin lesions. 30394605 2019
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
0.010 Biomarker disease BEFREE Also, complement-fixing IgG3 antibodies targeting paranodal proteins have been associated with acute-onset CIDP. 31306213 2019
Left ventricular diastolic dysfunction
0.010 AlteredExpression disease BEFREE Similarly, increased levels of circulating IgG1 and IgG3 were observed in men with left ventricular diastolic dysfunction (LVDD, n = 5), possibly an early stage of HF with preserved EF (HFpEF). 31557411 2019
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE As IgG3 plays a key role in counteracting the ability of HSV-1 to evade immune responses, these data reinforce the hypothesis of a pathogenetic role of HSV-1 in AD. 29578484 2018
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.010 AlteredExpression disease BEFREE Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. 30053866 2018
CUI: C0006840
Disease: Candidiasis
Candidiasis
0.010 Biomarker disease BEFREE Here, we report the development of a highly specific mouse IgG3 monoclonal antibody (MC3) that binds to a putative β-1,2-mannan epitope present in high molecular weight mannoproteins and phospholipomannans on the surface of yeast and hyphal morphotypes of <i>C. albicans</i>, and its use as a [<sup>64</sup>Cu]NODAGA-labeled tracer for whole-body pre-clinical imaging of deep-seated <i>C. albicans</i> infections using antibody-guided positron emission tomography and magnetic resonance imaging (immunoPET/MRI).When used in a mouse intravenous (i.v.) challenge model that faithfully mimics disseminated <i>C. albicans</i> infections in humans, the [<sup>64</sup>Cu]NODAGA-MC3 tracer accurately detects infections of the kidney, the principal site of blood-borne candidiasis in this model. 30190717 2018
Glomerulonephritis, Membranoproliferative
0.010 Biomarker disease BEFREE Membranoproliferative glomerulonephritis pattern with monoclonal IgG3 deposits is a common feature. 29616329 2018
CUI: C0024312
Disease: Lymphopenia
Lymphopenia
0.010 Biomarker disease BEFREE Mb1-aPIK3CD mice exhibited bone marrow B lymphopenia and, conversely, expansion of the peripheral innate B1a and MZ B cell compartments. aPIK3CD B cells manifest increased pS6 and increased survival at several stages, without alterations in cycling, and baseline increases in plasma cells, natural IgM, and IgG3. 30194267 2018
Monoclonal Gammopathy of Undetermined Significance
0.010 Biomarker disease BEFREE Serum protein electrophoresis (SPEP) and serum protein immunofixation electrophoresis (SPIFE) demonstrated monoclonal immunoglobulin G (IgG) κ restricted bands (IgG 3,820 mg/dL; κ/λ ratio 4.47), indicative of monoclonal gammopathy of unknown significance (MGUS). 30203743 2018
CUI: C0032269
Disease: Pneumococcal Infections
Pneumococcal Infections
0.010 Biomarker group BEFREE Nevertheless, CD73- or A2aR- deficient adult mice ultimately produced antigen-specific IgG3 and controlled Streptococcus pneumoniae infection as efficiently as wild type (WT) mice. 29377929 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.010 AlteredExpression disease BEFREE Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. 30053866 2018